Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18th

Cancer Genetics Will Also Present a Corporate Overview on Thursday, October 19th RUTHERFORD, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a...
September 29, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House

RUTHERFORD, N.J., Sept. 29, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and...
September 22, 2017 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Present at the 2017 Disruptive Growth Company Showcase NYC on September 27th

RUTHERFORD, N.J., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and...
September 20, 2017 09:21 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces 25th Contract Win to Provide Testing & Diagnostic Services for Combination Immuno-Oncology Clinical Trial

Nearly half of the 50+ Immuno-Oncology Clinical Trials that CGI is supporting are combination trials involving multiple oncology drugs. CGI expects enrollment of over 4,500 patients into these...
September 08, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City, September 10-12, 2017

RUTHERFORD, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (The Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and...
August 16, 2017 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Host Conference Call to Discuss Strategic and Business Rationale of vivoPharm Acquisition

RUTHERFORD, N.J. and LOS ANGELES, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (The Company and CGI), a leader in enabling precision medicine for oncology through molecular...
August 14, 2017 17:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Transformative and Accretive Acquisition of vivoPharm, a Global Oncology & Immuno-Oncology Discovery Services Company

Acquisition Strengthens CGI’s Bench-to-Bedside Capabilities and Bolsters Growth with Global Customer Base of Biopharma PartnersExpands Discovery and Early Development Revenue Base with Highly...
August 14, 2017 16:56 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise

Second quarter revenue of $6.6 millionRecord biopharma demand in quarter with $7.1 million in new contract bookings for Biopharma ServicesClinical Services Revenue up 20% over Q2 2016 to $3.0...
August 07, 2017 16:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Hold Second Quarter 2017 Earnings Call on Monday, August 14th

RUTHERFORD, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced...
August 03, 2017 07:30 ET | Source: Cancer Genetics, Inc.

DIA Elects Cancer Genetics, Inc.’s John A. (Jay) Roberts as Chairman of DIA Board of Directors

DIA is a professional community and knowledge exchange network for global health care product developmentMr. Roberts, who is also the Chief Operating Officer and EVP of Finance at Cancer Genetics,...